Titan Biotech 過去の業績
過去 基準チェック /36
Titan Biotech has been growing earnings at an average annual rate of 15.8%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 13.8% per year. Titan Biotech's return on equity is 18.8%, and it has net margins of 14.6%.
主要情報
15.8%
収益成長率
15.8%
EPS成長率
| Chemicals 業界の成長 | 17.7% |
| 収益成長率 | 13.8% |
| 株主資本利益率 | 18.8% |
| ネット・マージン | 14.6% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
収支内訳
Titan Biotech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 1,724 | 251 | 246 | 0 |
| 31 Mar 24 | 1,641 | 249 | 268 | 0 |
| 31 Dec 23 | 1,610 | 248 | 250 | 0 |
| 30 Sep 23 | 1,453 | 209 | 236 | 0 |
| 30 Jun 23 | 1,403 | 227 | 223 | 0 |
| 31 Mar 23 | 1,440 | 248 | 210 | 0 |
| 31 Dec 22 | 1,403 | 249 | 180 | 0 |
| 30 Sep 22 | 1,464 | 268 | 174 | 0 |
| 30 Jun 22 | 1,500 | 249 | 173 | 0 |
| 31 Mar 22 | 1,235 | 217 | 149 | 0 |
| 31 Dec 21 | 1,538 | 241 | 165 | 0 |
| 30 Sep 21 | 1,525 | 255 | 161 | 0 |
| 30 Jun 21 | 1,443 | 263 | 148 | 0 |
| 31 Mar 21 | 1,422 | 303 | 146 | 0 |
| 31 Dec 20 | 1,268 | 285 | 152 | 0 |
| 30 Sep 20 | 1,109 | 236 | 148 | 0 |
| 30 Jun 20 | 968 | 178 | 126 | 0 |
| 31 Mar 20 | 794 | 71 | 143 | 0 |
| 31 Dec 19 | 766 | 58 | 135 | 0 |
| 30 Sep 19 | 728 | 49 | 125 | 0 |
| 30 Jun 19 | 713 | 46 | 108 | 0 |
| 31 Mar 19 | 649 | 35 | 117 | 0 |
| 31 Dec 18 | 659 | 46 | 61 | 0 |
| 30 Sep 18 | 662 | 41 | 58 | 0 |
| 30 Jun 18 | 627 | 34 | 36 | 0 |
| 31 Mar 18 | 574 | 25 | 86 | 0 |
| 31 Dec 17 | 587 | 27 | 73 | 0 |
| 30 Sep 17 | 557 | 22 | 67 | 0 |
| 30 Jun 17 | 535 | 23 | 50 | 0 |
| 31 Mar 17 | 527 | 22 | 39 | 0 |
| 31 Dec 16 | 503 | 18 | 48 | 0 |
| 30 Sep 16 | 494 | 20 | 46 | 0 |
| 30 Jun 16 | 484 | 18 | 37 | 0 |
| 31 Mar 16 | 458 | 18 | 42 | 0 |
| 31 Dec 15 | 451 | 16 | 65 | 0 |
| 30 Sep 15 | 419 | 16 | 64 | 0 |
| 30 Jun 15 | 408 | 16 | 28 | 0 |
| 31 Mar 15 | 403 | 16 | 32 | 0 |
| 31 Dec 14 | 395 | 16 | 60 | 0 |
| 30 Sep 14 | 405 | 16 | 59 | 0 |
| 30 Jun 14 | 415 | 15 | 24 | 0 |
| 31 Mar 14 | 391 | 15 | 56 | 0 |
| 31 Dec 13 | 355 | 15 | 45 | 0 |
質の高い収益: 524717 has high quality earnings.
利益率の向上: 524717's current net profit margins (14.6%) are lower than last year (16.2%).
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 524717's earnings have grown by 15.8% per year over the past 5 years.
成長の加速: 524717's earnings growth over the past year (10.6%) is below its 5-year average (15.8% per year).
収益対業界: 524717 earnings growth over the past year (10.6%) exceeded the Chemicals industry 10.4%.
株主資本利益率
高いROE: 524717's Return on Equity (18.8%) is considered low.